This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
trigram | frequency |
---|---|
severe acute respiratory | 2897 |
acute respiratory syndrome | 2807 |
respiratory syndrome coronavirus | 2491 |
middle east respiratory | 1251 |
east respiratory syndrome | 1244 |
in patients with | 1136 |
of the sars | 1105 |
as well as | 1063 |
of the virus | 918 |
patients with covid | 909 |
of severe acute | 840 |
the treatment of | 728 |
the presence of | 715 |
of novel coronavirus | 703 |
the use of | 626 |
the development of | 624 |
the s protein | 543 |
due to the | 531 |
based on the | 505 |
the novel coronavirus | 493 |
a novel coronavirus | 493 |
one of the | 452 |
the spike protein | 448 |
for the treatment | 445 |
of patients with | 443 |
the number of | 430 |
cov cl pro | 427 |
patients with severe | 423 |
detection of sars | 410 |
respiratory distress syndrome | 407 |
in this study | 398 |
acute respiratory distress | 394 |
the risk of | 392 |
infected with sars | 390 |
n a l | 388 |
p r o | 388 |
o u r | 387 |
p r e | 387 |
a l p | 387 |
u r n | 387 |
j o u | 387 |
r o o | 387 |
o o f | 387 |
r n a | 387 |
l p r | 387 |
clinical characteristics of | 378 |
transmission of sars | 376 |
treatment of covid | 375 |
of the disease | 366 |
in addition to | 361 |
in order to | 357 |
of coronavirus disease | 353 |
the role of | 352 |
world health organization | 349 |
cov and mers | 342 |
of middle east | 329 |
according to the | 328 |
a systematic review | 324 |
patients infected with | 322 |
cov and sars | 321 |
patients with sars | 319 |
protein of sars | 312 |
the detection of | 307 |
found to be | 307 |
the severe acute | 301 |
novel coronavirus in | 297 |
structure of the | 294 |
of a novel | 294 |
the united states | 289 |
with severe acute | 288 |
of the s | 283 |
the spread of | 282 |
of sars coronavirus | 281 |
it has been | 281 |
with novel coronavirus | 281 |
the host cell | 279 |
novel coronavirus from | 278 |
associated with the | 276 |
been shown to | 275 |
the absence of | 270 |
of the novel | 265 |
associated with a | 265 |
in the treatment | 262 |
of the covid | 259 |
of the viral | 259 |
critically ill patients | 258 |
hospitalized patients with | 254 |
analysis of the | 253 |
a new coronavirus | 250 |
in the united | 248 |
the possibility of | 243 |
is associated with | 243 |
have been reported | 241 |
syndrome coronavirus infection | 235 |
role in the | 233 |
the onset of | 233 |
there is no | 233 |
the sars coronavirus | 233 |
with severe covid | 232 |
from patients with | 232 |
sars and mers | 230 |
a total of | 229 |
on the other | 227 |
related to the | 227 |
with coronavirus disease | 226 |
clinical features of | 225 |
vero e cells | 217 |
the immune system | 216 |
the other hand | 216 |
in the lungs | 214 |
in the sars | 213 |
novel coronavirus pneumonia | 213 |
dependent rna polymerase | 211 |
of patients infected | 211 |
has been reported | 210 |
such as the | 210 |
the expression of | 207 |
the ace receptor | 207 |
there is a | 205 |
the effect of | 205 |
was used to | 204 |
the s subunit | 203 |
in the absence | 203 |
has been shown | 202 |
viral load in | 201 |
was found to | 200 |
pneumonia in wuhan | 200 |
coronavirus spike protein | 200 |
involved in the | 199 |
the case of | 198 |
of viral rna | 198 |
of the spike | 198 |
a number of | 197 |
the time of | 196 |
the efficacy of | 196 |
this article is | 196 |
to the sars | 195 |
for disease control | 191 |
polymerase chain reaction | 190 |
control and prevention | 190 |
ace and tmprss | 189 |
the severity of | 189 |
the middle east | 188 |
in the case | 188 |
the pathogenesis of | 187 |
the copyright holder | 186 |
all rights reserved | 185 |
the context of | 185 |
compared to the | 185 |
disease control and | 184 |
cd t cells | 184 |
to display the | 183 |
the impact of | 182 |
during the covid | 181 |
at the time | 181 |
a license to | 181 |
the preprint in | 181 |
granted medrxiv a | 181 |
medrxiv a license | 181 |
has granted medrxiv | 181 |
who has granted | 181 |
the respiratory tract | 181 |
display the preprint | 181 |
license to display | 181 |
the production of | 180 |
systematic review and | 180 |
with pneumonia in | 180 |
of hospitalized patients | 179 |
in the context | 178 |
s and s | 178 |
of the coronavirus | 177 |
lower respiratory tract | 177 |
the coronavirus disease | 176 |
need to be | 176 |
in vitro and | 175 |
most of the | 175 |
in saudi arabia | 175 |
of convalescent plasma | 175 |
for the detection | 174 |
some of the | 174 |
can be used | 173 |
the importance of | 172 |
the majority of | 172 |
coronavirus associated with | 172 |
the world health | 171 |
central nervous system | 170 |
for the development | 170 |
to determine the | 169 |
spike protein of | 169 |
copyright holder for | 169 |
holder for this | 169 |
and treatment of | 168 |
were found to | 167 |
the course of | 167 |
a recent study | 166 |
presence of sars | 166 |
of the patients | 164 |
responses to sars | 164 |
as a result | 163 |
has also been | 163 |
responsible for the | 163 |
the emergence of | 162 |
understanding of the | 162 |
patients with coronavirus | 162 |
is the author | 161 |
in the s | 161 |
the author funder | 160 |
onset of symptoms | 159 |
treatment of sars | 158 |
disease in china | 157 |
in terms of | 157 |
spread of the | 157 |
positive for sars | 156 |
the binding of | 156 |
the virus to | 156 |
ill patients with | 155 |
is protected by | 155 |
has not been | 155 |
antibodies against sars | 155 |
protected by copyright | 155 |
to evaluate the | 155 |
article is protected | 155 |
in response to | 154 |
upper respiratory tract | 154 |
to be a | 154 |
for patients with | 154 |
the fact that | 154 |
is important to | 154 |
this version posted | 154 |
receptor binding domain | 153 |
infection with sars | 153 |
the end of | 153 |
be used to | 152 |
crystal structure of | 152 |
cov s protein | 152 |
review and meta | 152 |
it is important | 151 |
to be the | 151 |
detected in the | 151 |
novel coronavirus disease | 151 |
diagnosis of covid | 151 |
intensive care unit | 149 |
the results of | 149 |
a variety of | 149 |
showed that the | 148 |
with a new | 148 |
associated with sars | 147 |
well as the | 147 |
patients with pneumonia | 147 |
high levels of | 146 |
response to sars | 145 |
which was not | 145 |
cases of covid | 145 |
acute lung injury | 144 |
in hong kong | 144 |
part of the | 144 |
in the early | 143 |
features of patients | 143 |
in combination with | 143 |
spread of sars | 142 |
shown to be | 142 |
activation of the | 141 |
caused by sars | 141 |
the most common | 141 |
is responsible for | 140 |
a patient with | 140 |
as a potential | 140 |
by peer review | 139 |
angiotensin converting enzyme | 139 |
certified by peer | 139 |
infected with novel | 139 |
the outbreak of | 139 |
the virus in | 138 |
not certified by | 138 |
the virus and | 137 |
the surface of | 137 |
a review of | 137 |
was not certified | 137 |
in severe covid | 136 |
functional receptor for | 136 |
a pneumonia outbreak | 136 |
the authors declare | 136 |
was detected in | 136 |
structure of sars | 136 |
outbreak associated with | 136 |
t cell responses | 135 |
are associated with | 135 |
of the first | 135 |
as compared to | 135 |
probable bat origin | 134 |
origin of sars | 134 |
the lack of | 134 |
the need for | 134 |
have shown that | 133 |
for treatment of | 133 |
associated with severe | 133 |
for the sars | 133 |
as shown in | 132 |
the identification of | 132 |
human monoclonal antibody | 132 |
the immune response | 132 |
of s protein | 131 |
coronavirus disease in | 131 |
to reduce the | 131 |
new coronavirus of | 131 |
immune response to | 131 |
of the human | 131 |
of probable bat | 131 |
in the lung | 131 |
of cases of | 131 |
coronavirus of probable | 131 |
pneumonia outbreak associated | 131 |
cov spike protein | 130 |
in the human | 130 |
of the most | 130 |
in dromedary camels | 130 |
there are no | 130 |
expression of ace | 130 |
the virus is | 129 |
and clinical characteristics | 129 |
s protein of | 129 |
that can be | 128 |
that the virus | 128 |
to that of | 128 |
caused by the | 128 |
balb c mice | 128 |
on ace and | 127 |
used as a | 127 |
the diagnosis of | 127 |
with acute respiratory | 127 |
included in the | 127 |
the transmission of | 127 |
of the pandemic | 126 |
into host cells | 126 |
transmission of the | 126 |
risk factors for | 126 |
conflict of interest | 126 |
a combination of | 126 |
respiratory disease in | 126 |
the active site | 126 |
the entry of | 126 |
around the world | 126 |
entry depends on | 126 |
and characterization of | 126 |
pneumonia in china | 125 |
a result of | 125 |
a clinically proven | 125 |
depends on ace | 125 |
cell entry depends | 124 |
of critically ill | 124 |
coronavirus in wuhan | 124 |
is blocked by | 124 |
of the immune | 124 |
was performed using | 123 |
in rhesus macaques | 123 |
and tmprss and | 123 |
blocked by a | 123 |
cov infection in | 123 |
influenza a virus | 122 |
and is blocked | 122 |
by a clinically | 122 |
tmprss and is | 121 |
analysis of sars | 121 |
coronavirus infection in | 121 |
clinically proven protease | 121 |
viral rna in | 121 |
coronavirus from patients | 121 |
a role in | 121 |
in the study | 120 |
infection in the | 120 |
that of sars | 120 |
syndrome coronavirus in | 120 |
receptor for sars | 120 |
proven protease inhibitor | 120 |
been reported in | 120 |
in the presence | 119 |
present in the | 119 |
in the respiratory | 118 |
first case of | 118 |
associated with covid | 118 |
an important role | 118 |
development of a | 118 |
a study of | 118 |
the replication of | 118 |
the formation of | 117 |
vitro and in | 117 |
and evolution of | 117 |
be associated with | 117 |
more likely to | 117 |
there was no | 117 |
of the severe | 116 |
the effects of | 116 |
with the sars | 116 |
binding to the | 116 |
insights into the | 115 |
igm and igg | 115 |
characterization of the | 115 |
respiratory syncytial virus | 115 |
identification of a | 115 |
convalescent plasma therapy | 114 |
inhibition of sars | 114 |
of the infection | 114 |
shortness of breath | 114 |
found that the | 114 |
the receptor binding | 114 |
similar to the | 114 |
cov m pro | 114 |
patients in the | 113 |
been reported to | 113 |
the management of | 113 |
have also been | 113 |
to assess the | 113 |
a and b | 112 |
patients with novel | 112 |
the release of | 112 |
the incubation period | 112 |
of severe covid | 112 |
a descriptive study | 111 |
have been shown | 111 |
spike glycoprotein of | 111 |
to the virus | 110 |
antibody responses to | 110 |
it is not | 110 |
likely to be | 109 |
shown in figure | 109 |
was observed in | 109 |
is one of | 109 |
innate immune response | 109 |
receptor recognition by | 108 |
the spike glycoprotein | 108 |
and in vivo | 108 |
after the onset | 107 |
preprint in perpetuity | 107 |
should be considered | 107 |
transmission of covid | 107 |
entry into the | 107 |
domain of the | 107 |
mechanism of action | 107 |
closely related to | 107 |
implications for virus | 107 |
of this study | 107 |
found in the | 107 |
epidemiological and clinical | 106 |
appears to be | 106 |
prevention and control | 106 |
and receptor binding | 106 |
retrospective cohort study | 106 |
important role in | 106 |
response to the | 106 |
the level of | 106 |
were used to | 106 |
replication of sars | 106 |
for severe acute | 106 |
increased risk of | 105 |
on the surface | 105 |
of infected patients | 105 |
at room temperature | 105 |
to have a | 105 |
large number of | 105 |
and pathogenesis of | 104 |
efficacy and safety | 104 |
of the genome | 104 |
of the host | 104 |
the ability to | 104 |
in this review | 104 |
for detection of | 104 |
was associated with | 103 |
to prevent the | 103 |
a series of | 103 |
in the same | 103 |
the activation of | 103 |
cells in the | 103 |
seems to be | 103 |
are needed to | 103 |
is the most | 102 |
virus in the | 102 |
and safety of | 102 |
of sars cov | 102 |
by severe acute | 102 |
to understand the | 102 |
mutations in the | 102 |
consistent with the | 102 |
the viral genome | 102 |
amino acid residues | 102 |
studies of sars | 101 |
of neutralizing antibodies | 101 |
needs to be | 101 |
the duration of | 101 |
cd and cd | 101 |
s protein is | 101 |
in vero e | 101 |
personal protective equipment | 101 |
treatment of severe | 101 |
tested positive for | 100 |
it is possible | 100 |
role of the | 100 |
case of sars | 100 |
play a role | 100 |
li et al | 100 |
and epidemiology of | 100 |
characterization of a | 100 |
the prevalence of | 100 |
studies have shown | 100 |
due to its | 100 |
into the host | 100 |
syndrome coronavirus spike | 100 |
in case of | 100 |
randomized clinical trial | 99 |
activity against sars | 99 |
the ability of | 99 |
a report of | 99 |
in critically ill | 99 |
days after the | 99 |
morbidity and mortality | 99 |
in our study | 99 |
observed in the | 98 |
of the study | 98 |
used in the | 98 |
human immunodeficiency virus | 98 |
in the spike | 98 |
than that of | 98 |
systematic review of | 98 |
a functional receptor | 98 |
reported to be | 98 |
in the first | 97 |
in clinical trials | 97 |
we found that | 97 |
receptor for the | 97 |
the beginning of | 97 |
detection of novel | 96 |
the effectiveness of | 96 |
coronavirus in the | 96 |
for coronavirus disease | 96 |
used for the | 96 |
addition to the | 96 |
contribute to the | 96 |
characteristics of cases | 96 |
the basis of | 95 |
review of the | 95 |
structural basis for | 95 |
in the future | 95 |
close contact with | 95 |
virus origins and | 94 |
with the novel | 94 |
associated with human | 94 |
region of the | 94 |
the virus was | 94 |
obtained from the | 94 |
for virus origins | 94 |
in accordance with | 94 |
epidemiology of novel | 94 |
can also be | 94 |
yet to be | 94 |
diffuse alveolar damage | 94 |
type i interferon | 94 |
are known to | 94 |
binds to the | 94 |
the potential for | 94 |
em structure of | 94 |
origins and receptor | 93 |
the inhibition of | 93 |
have been identified | 93 |
health care workers | 93 |
diagnosis of sars | 93 |
analysis based on | 92 |
be used for | 92 |
respiratory syndrome in | 92 |
different types of | 92 |
a retrospective cohort | 92 |
used to treat | 92 |
a history of | 92 |
in the current | 92 |
evolution of the | 92 |
that of the | 92 |
incubation period of | 92 |
for this preprint | 92 |
with regard to | 91 |
the cytokine storm | 91 |
genomic characterisation and | 91 |
been detected in | 91 |
spike protein and | 91 |
remains to be | 91 |
characterisation and epidemiology | 91 |
of human coronavirus | 91 |
risk of sars | 91 |
by the novel | 90 |
cases of sars | 90 |
that the sars | 90 |
for h at | 90 |
the viral rna | 90 |
of the outbreak | 90 |
the lungs of | 89 |
an increase in | 89 |
inhibition of the | 89 |
human respiratory disease | 89 |
the n protein | 89 |
years of age | 89 |
been associated with | 89 |
nsp and nsp | 89 |
centers for disease | 89 |
binding domain of | 89 |
susceptible to sars | 89 |
approved by the | 89 |
similar to that | 89 |
entry of sars | 89 |
may not be | 88 |
during the sars | 88 |
after symptom onset | 88 |
clinical course and | 88 |
is essential for | 88 |
is based on | 88 |
to the host | 88 |
to treat covid | 88 |
between the two | 88 |
s protein and | 87 |
can lead to | 87 |
in sars patients | 87 |
the potential to | 87 |
could be a | 87 |
an outbreak of | 87 |
of the ace | 87 |
the central nervous | 87 |
a case report | 87 |
the viral load | 87 |
diagnosis and treatment | 87 |
a family cluster | 87 |
for the diagnosis | 87 |
prevention and treatment | 87 |
which is a | 86 |
the origin of | 86 |
and cd t | 86 |
the interaction of | 86 |
new coronavirus associated | 86 |
with human respiratory | 86 |
the host cells | 86 |
manifestations of covid | 86 |
higher risk of | 86 |
end of the | 85 |
cells of the | 85 |
the present study | 85 |
the design of | 85 |
it should be | 85 |
associated with acute | 85 |
no evidence of | 85 |
to be more | 85 |
wang et al | 85 |
wide range of | 85 |
the upper respiratory | 85 |
based on a | 85 |
antiviral activity of | 85 |
expression of the | 85 |
may be a | 85 |
to control the | 85 |
hydroxychloroquine and azithromycin | 84 |
of type i | 84 |
because of the | 84 |
in severe acute | 84 |
coronavirus pneumonia in | 84 |
pathogenesis of sars | 84 |
the discovery of | 84 |
detection of the | 84 |
cytokines and chemokines | 84 |
in contrast to | 84 |
is a functional | 84 |
the human population | 84 |
it is also | 84 |
the cells were | 84 |
was carried out | 84 |
there is an | 84 |
the patient was | 84 |
may also be | 84 |
in the past | 84 |
spread of covid | 83 |
of action of | 83 |
center for disease | 83 |
structural and functional | 83 |
caused by a | 83 |
to detect sars | 82 |
to investigate the | 82 |
suggest that the | 82 |
a wide range | 82 |
are shown in | 82 |
on the basis | 82 |
infected by sars | 82 |
as part of | 82 |
entry into host | 82 |
in the development | 82 |
negative for sars | 82 |
at the same | 82 |
was shown to | 82 |
cases of novel | 82 |
in hospitalized patients | 82 |
in coronavirus disease | 82 |
of the world | 82 |
and outcomes of | 82 |
factors associated with | 82 |
against the sars | 81 |
are involved in | 81 |
inhibitors of sars | 81 |
the analysis of | 81 |
were detected in | 81 |
for novel coronavirus | 81 |
isolated from a | 81 |
may lead to | 81 |
the amount of | 81 |
is consistent with | 81 |
the rbd of | 81 |
the mechanism of | 81 |
be due to | 81 |
in animal models | 81 |
the new coronavirus | 81 |
similar to sars | 81 |
it is a | 80 |
the virus can | 80 |
which can be | 80 |
an overview of | 80 |
in cell culture | 80 |
and middle east | 80 |
igg and igm | 80 |
for min at | 80 |
in a study | 80 |
to the ace | 80 |
the general population | 79 |
suggests that the | 79 |
this study was | 79 |
and it is | 79 |
study of a | 79 |
viral replication and | 79 |
the activity of | 79 |
compared with the | 79 |
each of the | 79 |
in the upper | 78 |
in the prefusion | 78 |
clinical trials are | 78 |
in the brain | 78 |
viral rna was | 78 |
no conflict of | 78 |
and development of | 78 |
and in the | 78 |
antigenicity of the | 78 |
authors declare no | 78 |
of this virus | 78 |
of the manuscript | 77 |
the prefusion conformation | 77 |
for this this | 77 |
this this version | 77 |
have not been | 77 |
patients with mild | 77 |
immune response in | 77 |
and immunogenicity of | 77 |
be used as | 77 |
changes in the | 77 |
evaluation of the | 77 |
remdesivir and chloroquine | 77 |
none of the | 77 |
the viral infection | 77 |
transmission dynamics in | 77 |
cd t cell | 77 |
by the virus | 77 |
to identify the | 77 |
it is made | 77 |
binding of the | 77 |
have been used | 76 |
chloroquine and hydroxychloroquine | 76 |
may contribute to | 76 |
in the viral | 76 |
for the prevention | 76 |
compared to sars | 76 |
structural studies of | 76 |
sars coronavirus infection | 76 |
the university of | 76 |
as a possible | 76 |
is made available | 76 |
the prevention and | 76 |
of a sars | 76 |
with or without | 76 |
made available under | 75 |
shown in table | 75 |
activity of the | 75 |
cluster of pneumonia | 75 |
license it is | 75 |
also known as | 75 |
risk factor for | 75 |
hepatitis c virus | 75 |
in the present | 75 |
in the pathogenesis | 75 |
we did not | 75 |
that there is | 75 |
safety and immunogenicity | 75 |
spike in the | 75 |
of the current | 75 |
effectively inhibit the | 75 |
international license it | 75 |
available under a | 75 |
patients with a | 74 |
orf a and | 74 |
the same time | 74 |
the interaction between | 74 |
a group of | 74 |
as previously described | 74 |
the s domain | 74 |
be detected in | 74 |
immune responses to | 74 |
familial cluster of | 74 |
treatment of patients | 74 |
chen et al | 74 |
be involved in | 74 |
the proportion of | 74 |
the recently emerged | 74 |
t cells in | 73 |
a large number | 73 |
suggesting that the | 73 |
when compared to | 73 |
and antigenicity of | 73 |
early stages of | 73 |
is the first | 73 |
are likely to | 73 |
that have been | 73 |
regions of the | 73 |
isolation and characterization | 73 |
ncov spike in | 73 |
parts of the | 73 |
surface of the | 73 |
sars coronavirus spike | 73 |
the sensitivity of | 73 |
be able to | 73 |
proteins of sars | 72 |
the current pandemic | 72 |
human transmission of | 72 |
immune responses in | 72 |
of ace in | 72 |
thermo fisher scientific | 72 |
would like to | 72 |
a familial cluster | 72 |
suggested that the | 72 |
is likely to | 72 |
the induction of | 72 |
a range of | 72 |
respiratory tract infections | 72 |
are required to | 72 |
at the end | 72 |
of lopinavir ritonavir | 72 |
infection in a | 72 |
sequence of the | 72 |
in these patients | 72 |
neutralizing antibodies against | 72 |
in which the | 72 |
genome sequence of | 71 |
authors declare that | 71 |
novel human coronavirus | 71 |
revealed that the | 71 |
by the sars | 71 |
course of the | 71 |
coronavirus from wuhan | 71 |
emergence of sars | 71 |
severity of the | 71 |
be related to | 71 |
has been observed | 71 |
the innate immune | 71 |
epithelial cells and | 71 |
interaction with the | 71 |
an analysis based | 71 |
the amino acid | 71 |
basis for the | 71 |
airway epithelial cells | 71 |
which may be | 71 |
food and drug | 70 |
infected pneumonia in | 70 |
were observed in | 70 |
contributed to the | 70 |
the availability of | 70 |
infection in vitro | 70 |
in the host | 70 |
inhibit the recently | 70 |
infection by sars | 70 |
considered to be | 70 |
found to have | 70 |
symptoms of covid | 70 |
emerged novel coronavirus | 70 |
mice infected with | 70 |
the lower respiratory | 70 |
appear to be | 70 |
chloroquine effectively inhibit | 70 |
stability of sars | 70 |
study of the | 70 |
recently emerged novel | 70 |
antibodies to sars | 69 |
inhibitors of the | 69 |
increase in the | 69 |
of the n | 69 |
the d g | 69 |
related to sars | 69 |
is possible that | 69 |
due to a | 69 |
been observed in | 69 |
was added to | 69 |
novel coronavirus indicating | 69 |
the main protease | 69 |
was used as | 69 |
and chloroquine effectively | 69 |
mouse hepatitis virus | 69 |
characteristics of coronavirus | 69 |
of the epidemic | 69 |
in the olfactory | 69 |
cov pl pro | 69 |
vaccine against sars | 69 |
traditional chinese medicine | 69 |
ace expression in | 69 |
for the covid | 69 |
in a recent | 69 |
and can be | 68 |
derived from the | 68 |
the setting of | 68 |
preprint this version | 68 |
along with the | 68 |
pneumonia associated with | 68 |
can be detected | 68 |
in line with | 68 |
in complex with | 68 |
this preprint this | 68 |
the causative agent | 68 |
characteristics of hospitalized | 68 |
stage of the | 68 |
antiviral activity against | 68 |
clinical characteristics and | 68 |
due to their | 68 |
during the early | 68 |
the occurrence of | 67 |
coronavirus from a | 67 |
for at least | 67 |
bind to the | 67 |
as compared with | 67 |
preprint the copyright | 67 |
there have been | 67 |
of the new | 67 |
the host immune | 67 |
against the virus | 67 |
a crucial role | 67 |
human monoclonal antibodies | 67 |
of the same | 67 |
recognition by the | 67 |
the crystal structure | 67 |
supported by the | 67 |
replication and pathogenesis | 67 |
infection of sars | 67 |
a cluster of | 67 |
of viral replication | 67 |
a higher risk | 67 |
in southern china | 67 |
of the clinical | 67 |
based on decade | 67 |
any of the | 67 |
is able to | 67 |
case fatality rate | 67 |
in relation to | 67 |
the structure of | 67 |
for middle east | 67 |
sensitivity and specificity | 67 |
depending on the | 67 |
in a patient | 67 |
type i ifn | 67 |
to inhibit the | 66 |
members of the | 66 |
tumor necrosis factor | 66 |
a key role | 66 |
dynamics in wuhan | 66 |
with a high | 66 |
early transmission dynamics | 66 |
of a family | 66 |
in the setting | 66 |
results suggest that | 66 |
case of covid | 66 |
the cardiovascular system | 66 |
such as sars | 66 |
the nucleocapsid protein | 66 |
compared with sars | 66 |
there was a | 66 |
with respect to | 66 |
novel coronavirus associated | 66 |
should not be | 66 |
all of the | 66 |
of pneumonia associated | 66 |
similar to those | 65 |
severity of covid | 65 |
outbreak of sars | 65 |
host cell entry | 65 |
epithelial cells of | 65 |
has been used | 65 |
the s s | 65 |
long structural studies | 65 |
presence of the | 65 |
reported in the | 65 |
the efficacy and | 65 |
during the first | 65 |
known to be | 65 |
cytokine release syndrome | 65 |
human airway epithelial | 65 |
and drug administration | 65 |
rna in the | 65 |
samples were collected | 65 |
in the usa | 65 |
the combination of | 65 |
the olfactory epithelium | 65 |
demonstrated that the | 65 |
is necessary to | 65 |
from a patient | 65 |
can be found | 65 |
the most important | 65 |
results of the | 65 |
of the mers | 65 |
the common cold | 65 |
was supported by | 64 |
has been found | 64 |
evolution of sars | 64 |
reported that the | 64 |
report of cases | 64 |
patients admitted to | 64 |
infected with the | 64 |
type i and | 64 |
active site of | 64 |
identification of the | 64 |
patients with cancer | 64 |
rna was detected | 64 |
the control of | 64 |
the evolution of | 64 |
bound to the | 64 |
genomic characterization of | 64 |
serve as a | 64 |
other respiratory viruses | 64 |
have been developed | 64 |
the olfactory bulb | 64 |
safety and efficacy | 64 |
were able to | 64 |
in comparison to | 64 |
early stage of | 64 |
stages of the | 64 |
is involved in | 64 |
inflammatory cytokines and | 64 |
transmembrane serine protease | 64 |
is mediated by | 64 |
the potential of | 64 |
implications for the | 64 |
onset of illness | 63 |
is supported by | 63 |
located in the | 63 |
to the viral | 63 |
and orf b | 63 |
at the s | 63 |
number of patients | 63 |
the virus from | 63 |
data suggest that | 63 |
for up to | 63 |
and viral load | 63 |
the rate of | 63 |
to be effective | 63 |
mediated by the | 63 |
in some cases | 63 |
multiple sequence alignment | 63 |
were treated with | 63 |
it can be | 63 |
a lack of | 63 |
for the first | 63 |
at least one | 63 |
were obtained from | 63 |
of viral load | 63 |
the early stage | 63 |
neutralizing antibody responses | 63 |
admitted to the | 62 |
the performance of | 62 |
the intensive care | 62 |
host immune response | 62 |
is similar to | 62 |
is required for | 62 |
entry of the | 62 |
was used for | 62 |
isolation of a | 62 |
nature of the | 62 |
of these patients | 62 |
zhou et al | 62 |
detection of viral | 62 |
to develop a | 62 |
as described above | 62 |
structural basis of | 62 |
been found to | 62 |
some of these | 62 |
observational cohort study | 62 |
and control of | 62 |
in the air | 62 |
mesenchymal stem cells | 61 |
case of novel | 61 |
exposure to sars | 61 |
cause of severe | 61 |
a mouse model | 61 |
to severe acute | 61 |
is caused by | 61 |
the existence of | 61 |
were used for | 61 |
patients treated with | 61 |
with convalescent plasma | 61 |
of the receptor | 61 |
sequence of sars | 61 |
of a new | 61 |
a subset of | 61 |
virus infection in | 61 |
data not shown | 61 |
in the covid | 61 |
amino acid sequence | 60 |
the extent of | 60 |
of spike protein | 60 |
the result of | 60 |
from the coronavirus | 60 |
belongs to the | 60 |
to the human | 60 |
better understanding of | 60 |
alveolar epithelial cells | 60 |
outbreak in china | 60 |
is an important | 60 |
of acute respiratory | 60 |
the viral spike | 60 |
open reading frames | 60 |
total number of | 60 |
to detect the | 60 |
antibodies against the | 60 |
sequences of sars | 60 |
the safety and | 60 |
the addition of | 60 |
mild to moderate | 60 |
version posted september | 60 |
the genome of | 60 |
the plasma membrane | 60 |
and that the | 60 |
key role in | 60 |
as in the | 60 |
for the presence | 59 |
could not be | 59 |
in vitro studies | 59 |
infection of human | 59 |
an observational cohort | 59 |
emergency use authorization | 59 |
study showed that | 59 |
results showed that | 59 |
as a treatment | 59 |
zhang et al | 59 |
and management of | 59 |
are based on | 59 |
is known to | 59 |
neutralizing antibodies in | 59 |
symptoms such as | 59 |
with the host | 59 |
disease caused by | 59 |
cell entry and | 59 |
spike protein by | 59 |
in humans and | 59 |
were collected from | 59 |
to study the | 59 |
added to the | 59 |
corona virus disease | 59 |
viral shedding and | 59 |
glycoprotein of sars | 59 |
mechanisms of action | 59 |
in this context | 59 |
beginning of the | 59 |
coronavirus spike proteins | 59 |
yang et al | 59 |
are responsible for | 59 |
of the middle | 59 |
development of vaccines | 59 |
to note that | 59 |
d g mutation | 59 |
of clinical specimens | 59 |
an analysis of | 58 |
outbreak of covid | 58 |
lead to the | 58 |
of the infected | 58 |
the recognition of | 58 |
the first case | 58 |
this is the | 58 |
in another study | 58 |
as described previously | 58 |
isolated from the | 58 |
the percentage of | 58 |
with middle east | 58 |
the virus has | 58 |
levels of il | 58 |
chinese center for | 58 |
a case of | 58 |
the human ace | 58 |
of amino acid | 58 |
for the virus | 58 |
to the development | 58 |
the early stages | 58 |
coronavirus indicating person | 58 |
well as in | 58 |
been used to | 58 |
are essential for | 58 |
the cell surface | 58 |
hospitalized with severe | 58 |
thought to be | 58 |
pp a and | 58 |
was reported in | 58 |
outbreak of severe | 58 |
coronavirus in patients | 58 |
for sars coronavirus | 58 |
the in vitro | 58 |
lead to a | 58 |
leading to the | 58 |
neutralization of sars | 57 |
the international committee | 57 |
an increased risk | 57 |
the relationship between | 57 |
has been detected | 57 |
it was found | 57 |
be a potential | 57 |
were infected with | 57 |
it may be | 57 |
pathogenesis of covid | 57 |
novel coronavirus infection | 57 |
is no evidence | 57 |
that they have | 57 |
s subunit of | 57 |
during the course | 57 |
risk of infection | 57 |
a case series | 57 |
more than of | 57 |
the arabian peninsula | 57 |
indicate that the | 57 |
cov in the | 57 |
acute kidney injury | 57 |
further studies are | 57 |
of the two | 57 |
international committee on | 57 |
many of the | 57 |
and identification of | 57 |
cells infected with | 57 |
be considered as | 57 |
is needed to | 57 |
member of the | 57 |
was able to | 57 |
phase of the | 56 |
new york city | 56 |
control of the | 56 |
mouse model of | 56 |
could be used | 56 |
man with pneumonia | 56 |
clinical trials for | 56 |
virus entry and | 56 |
origin and evolution | 56 |
impact on the | 56 |
no competing interests | 56 |
of viral infection | 56 |
may play a | 56 |
pneumonia in saudi | 56 |
species severe acute | 56 |
together with the | 56 |
has been suggested | 56 |
innate immune responses | 56 |
of human coronaviruses | 56 |
that could be | 56 |
of the rna | 56 |
from a man | 56 |
this work was | 56 |
a global pandemic | 56 |
novel coronavirus outbreak | 56 |
mediated isothermal amplification | 56 |
higher than that | 56 |
by the world | 56 |
a man with | 56 |
t cells were | 56 |
of transmission of | 55 |
a target for | 55 |
wu et al | 55 |
is thought to | 55 |
studies are needed | 55 |
h n influenza | 55 |
origin of the | 55 |
on taxonomy of | 55 |
and risk factors | 55 |
a and pp | 55 |
up to days | 55 |
were positive for | 55 |
it is likely | 55 |
replication in the | 55 |
infectious bronchitis virus | 55 |
human coronavirus nl | 55 |
in this regard | 55 |
seem to be | 55 |
committee on taxonomy | 55 |
that has been | 55 |
the frequency of | 55 |
studies on the | 55 |
seroprevalence of sars | 55 |
of ace and | 55 |
infection in humans | 55 |
and pp ab | 55 |
the s glycoprotein | 55 |
the incidence of | 55 |
of proinflammatory cytokines | 55 |
and igg antibodies | 55 |
led to the | 55 |
from the chinese | 55 |
inhibitor of sars | 55 |
elevated levels of | 55 |
was isolated from | 55 |
of inflammatory cytokines | 55 |
have been described | 55 |
that it is | 55 |
national institute of | 54 |
shown that the | 54 |
was identified as | 54 |
signs and symptoms | 54 |
the process of | 54 |
the generation of | 54 |
its spike protein | 54 |
were found in | 54 |
shown in fig | 54 |
first step in | 54 |
human ace receptor | 54 |
our understanding of | 54 |
respiratory tract of | 54 |
with the virus | 54 |
structures of the | 54 |
out of the | 54 |
in the p | 54 |
aerosol and surface | 54 |
this is a | 54 |
due to sars | 54 |
site of sars | 54 |
is required to | 54 |
the prevention of | 54 |
and severity of | 54 |
the species severe | 54 |
number of cases | 54 |
a trial of | 54 |
prevalence of sars | 54 |
of a patient | 54 |
in the population | 54 |
is essential to | 53 |
patient with covid | 53 |
hr and hr | 53 |
and naming it | 53 |
but not in | 53 |
convalescent plasma for | 53 |
contact with the | 53 |
respiratory tract infection | 53 |
to better understand | 53 |
data indicate that | 53 |
may be the | 53 |
viral loads in | 53 |
confirmed cases of | 53 |
treatment of the | 53 |
hek t cells | 53 |
the cause of | 53 |
is due to | 53 |
of immune response | 53 |
patients hospitalized with | 53 |
the sars outbreak | 53 |
in new york | 53 |
they have no | 53 |
viral entry into | 53 |
coronavirus isolated from | 53 |
rapid spread of | 53 |
data on the | 53 |
on the sars | 53 |
of sars and | 53 |
viruses such as | 53 |
a better understanding | 53 |
the outcome of | 53 |
were associated with | 53 |
naming it sars | 53 |
protein is a | 53 |
identified in the | 53 |
resulted in a | 53 |
the synthesis of | 53 |
of patients who | 53 |
spike protein is | 53 |
insight into the | 53 |
ncov and naming | 53 |
across the globe | 52 |
has shown that | 52 |
this study is | 52 |
the possibility that | 52 |
be found in | 52 |
converting enzyme is | 52 |
t cells and | 52 |
viral load and | 52 |
airborne transmission of | 52 |
potential of sars | 52 |
information on the | 52 |
of the protein | 52 |
to be determined | 52 |
ranging from to | 52 |
play an important | 52 |
in severe cases | 52 |
differences in the | 52 |
has been demonstrated | 52 |
was found that | 52 |
has been described | 52 |
use of convalescent | 52 |
was performed on | 52 |
for design of | 52 |
of ebola virus | 52 |
antibody responses in | 52 |
plasma therapy in | 52 |
and public health | 52 |
open reading frame | 52 |
limit of detection | 52 |
herpes simplex virus | 52 |
characteristics of the | 52 |
causative agent of | 52 |
antibodies in the | 52 |
of the enzyme | 52 |
of spike glycoprotein | 52 |
bronchoalveolar lavage fluid | 52 |
of influenza virus | 51 |
declare that they | 51 |
prior to the | 51 |
host cell membrane | 51 |
was found in | 51 |
are the most | 51 |
domain of sars | 51 |
be noted that | 51 |
the mortality rate | 51 |
innate and adaptive | 51 |
the novel human | 51 |
reduce the risk | 51 |
majority of the | 51 |
use of the | 51 |
the application of | 51 |
also been reported | 51 |
s protein in | 51 |
with lopinavir ritonavir | 51 |
which in turn | 51 |
in this case | 51 |
to be used | 51 |
human coronavirus oc | 51 |
and has been | 51 |
was reported to | 51 |
of the drug | 51 |
features of covid | 51 |
with that of | 51 |
linked immunosorbent assay | 51 |
types of clinical | 51 |
in patients who | 51 |
which has been | 51 |
of the following | 51 |
the lungs and | 51 |
the epidemiology of | 51 |
in patients infected | 51 |
public health emergency | 51 |
in the following | 51 |
the nervous system | 51 |
emerging infectious diseases | 51 |
clinical course of | 50 |
during the pandemic | 50 |
multisystem inflammatory syndrome | 50 |
and efficacy of | 50 |
interaction between the | 50 |
human coronavirus e | 50 |
of hydroxychloroquine in | 50 |
host cell receptor | 50 |
the functional receptor | 50 |
it will be | 50 |
randomized controlled trial | 50 |
enzyme is a | 50 |
length human ace | 50 |
which is the | 50 |
have been found | 50 |
immune response and | 50 |
by a novel | 50 |
infection of the | 50 |
been shown that | 50 |
viral replication in | 50 |
in the elderly | 50 |
a and orf | 50 |
of the nsp | 50 |
this suggests that | 50 |
the viral replication | 50 |
in different types | 50 |
lessons from the | 50 |
cov infection and | 50 |
a cytokine storm | 50 |
and discovery of | 50 |
mechanisms of sars | 50 |
was obtained from | 50 |
in china and | 50 |
samples from the | 50 |
were reported in | 50 |
infection and the | 50 |
of infection and | 50 |
is difficult to | 50 |
of angiotensin converting | 50 |
were shown to | 50 |
the total number | 49 |
characteristics of patients | 49 |
mortality rate of | 49 |
potential role of | 49 |
were identified as | 49 |
x x x | 49 |
were performed using | 49 |
in the receptor | 49 |
potent inhibitor of | 49 |
basis for design | 49 |
nucleic acid detection | 49 |
syndrome associated with | 49 |
important to note | 49 |
depends on the | 49 |
more susceptible to | 49 |
for use in | 49 |
a clinical trial | 49 |
number of infected | 49 |
from the sars | 49 |
management of covid | 49 |
is composed of | 49 |
have been proposed | 49 |
the virus may | 49 |
indicated that the | 49 |
aspects of the | 49 |
and mortality in | 49 |
in the world | 49 |
to the s | 49 |
of the olfactory | 49 |
disease severity in | 49 |
results in the | 49 |
and approved the | 49 |
linked to the | 49 |
before and after | 49 |
not yet been | 49 |
of the international | 49 |
of the total | 49 |
are able to | 49 |
presence of a | 49 |
cases from the | 49 |
is also a | 49 |
identified as the | 49 |
in the literature | 49 |
is believed to | 49 |
outcomes of patients | 48 |
viral spike protein | 48 |
upper and lower | 48 |
the creative commons | 48 |
for vaccine development | 48 |
who did not | 48 |
upper respiratory specimens | 48 |
identification of potential | 48 |
transmission of mers | 48 |
assessment of hospitalized | 48 |
should be noted | 48 |
the family coronaviridae | 48 |
have been observed | 48 |
domain complexed with | 48 |
of infected individuals | 48 |
cytokine storm and | 48 |
virological assessment of | 48 |
has been identified | 48 |
the acute phase | 48 |
belong to the | 48 |
cov infected patients | 48 |
summary of a | 48 |
the rest of | 48 |
the infection of | 48 |
antibody to sars | 48 |
a risk factor | 48 |
like cleavage site | 48 |
is important for | 48 |
of coronavirus spike | 48 |
clinical management of | 48 |
adults hospitalized with | 48 |
accordance with the | 48 |
focused on the | 48 |
patients who have | 48 |
evolution of pathogenic | 48 |
immune response against | 48 |
the viral envelope | 48 |
is a major | 48 |
an in silico | 48 |
fatality rate of | 48 |
novel coronavirus sars | 48 |
of pathogenic coronaviruses | 48 |
high risk of | 48 |
diagnosed with covid | 48 |
at least two | 48 |
tests for sars | 48 |
version of the | 48 |
one or more | 48 |
in vitro antiviral | 48 |
prophylactic and therapeutic | 48 |
information about the | 47 |
to determine if | 47 |
been found in | 47 |
is a potent | 47 |
is shown in | 47 |
spike protein for | 47 |
feline infectious peritonitis | 47 |
taxonomy of viruses | 47 |
bronchial epithelial cells | 47 |
as it is | 47 |
coronavirus infection and | 47 |
may result in | 47 |
the levels of | 47 |
findings suggest that | 47 |
the proximal origin | 47 |
in the last | 47 |
in adults hospitalized | 47 |
in upper respiratory | 47 |
available in the | 47 |
drugs and vaccines | 47 |
for severe covid | 47 |
vesicular stomatitis virus | 47 |
the study was | 47 |
creative commons attribution | 47 |
results of an | 47 |
to improve the | 47 |
expressed in the | 47 |
high level of | 47 |
ribavirin and interferon | 47 |
of clinical trials | 47 |
for the management | 47 |
lopinavir and ritonavir | 47 |
to be an | 47 |
the function of | 47 |
proximal origin of | 47 |
the range of | 47 |
a is the | 47 |
humoral immune response | 47 |
for public health | 47 |
associated with an | 47 |
it would be | 47 |
pregnant women with | 47 |
at higher risk | 47 |
to block the | 47 |
increase the risk | 47 |
global public health | 47 |
all over the | 47 |
the hypothesis that | 47 |
of a vaccine | 47 |
the chinese center | 47 |
the s and | 47 |
used in this | 47 |
evidence of sars | 47 |
risk of covid | 47 |
in the lower | 47 |
coronavirus spike glycoprotein | 47 |
to those of | 47 |
of t cell | 46 |
and other coronaviruses | 46 |
expression in the | 46 |
at the beginning | 46 |
to be associated | 46 |
days after symptom | 46 |
that there are | 46 |
with and without | 46 |
phylogenetic analysis of | 46 |
drug discovery and | 46 |
serum samples from | 46 |
in the community | 46 |
did not show | 46 |
interactions with the | 46 |
has been proposed | 46 |
fusion of the | 46 |
will need to | 46 |
could lead to | 46 |
in a single | 46 |
the respiratory system | 46 |
higher levels of | 46 |
of ace receptor | 46 |
urgent need for | 46 |
showed that sars | 46 |
identified as a | 46 |
of the population | 46 |
the fusion of | 46 |
of children with | 46 |
for the recognition | 46 |
recovered from covid | 46 |
binding to ace | 46 |
that may be | 46 |
cl pro and | 46 |
in human airway | 46 |
acute respiratory disease | 46 |
form of the | 46 |
for the novel | 46 |
of the lung | 46 |
dependent enhancement of | 46 |
of at least | 46 |
transcription polymerase chain | 46 |
cells were washed | 46 |
were included in | 46 |
adaptive immune responses | 46 |
in the middle | 46 |
the sars epidemic | 46 |
outcomes of critically | 45 |
analysis was performed | 45 |
across the world | 45 |
and the other | 45 |
dromedary camels in | 45 |
to the same | 45 |
group of the | 45 |
infected with covid | 45 |
evidence suggests that | 45 |
described in the | 45 |
viral load of | 45 |
binding domain complexed | 45 |
serum samples were | 45 |
animal models of | 45 |
to be infected | 45 |
there are many | 45 |
in china a | 45 |
based on these | 45 |
as of april | 45 |
were used as | 45 |
in infected patients | 45 |
is that the | 45 |
to confirm the | 45 |
is characterized by | 45 |
rate of sars | 45 |
coronavirus nucleocapsid protein | 45 |
previous studies have | 45 |
analysis of a | 45 |
site of the | 45 |
viral infection and | 45 |
summarized in table | 45 |
drugs against sars | 45 |
results of a | 45 |
a decrease in | 45 |
is likely that | 45 |
severe cases of | 45 |
viral nucleic acid | 45 |
in vero cells | 45 |
residues in the | 45 |
use of a | 45 |
could be the | 45 |
cleavage of the | 45 |
state of the | 45 |
is a novel | 45 |
in health care | 45 |
to be highly | 45 |
among patients with | 45 |
and severe acute | 45 |
the association between | 45 |
for diagnosis of | 45 |
risk of death | 45 |
factors for mortality | 45 |
with more than | 45 |
protein data bank | 45 |
and transmission of | 45 |
in the second | 45 |
in the blood | 45 |
neurological manifestations of | 45 |
the distribution of | 45 |
of these drugs | 45 |
followed by a | 45 |
protein and the | 45 |
in peripheral blood | 45 |
of antibodies against | 44 |
for more than | 44 |
associated with increased | 44 |
was identified in | 44 |
these results suggest | 44 |
in the number | 44 |
and prevention of | 44 |
remains neutral with | 44 |
early in the | 44 |
a human monoclonal | 44 |
induced lung injury | 44 |
a randomized clinical | 44 |
cytokine storm in | 44 |
syndrome coronavirus and | 44 |
the antiviral activity | 44 |
acute respiratory infections | 44 |
under a is | 44 |
the origin and | 44 |
immune responses and | 44 |
born to mothers | 44 |
s protein to | 44 |
it is unclear | 44 |
the progression of | 44 |
in this paper | 44 |
on the s | 44 |
published maps and | 44 |
claims in published | 44 |
neutral with regard | 44 |
vertical transmission of | 44 |
by the viral | 44 |
effects on the | 44 |
the genome sequence | 44 |
to jurisdictional claims | 44 |
been reported that | 44 |
and institutional affiliations | 44 |
to the covid | 44 |
over the world | 44 |
safe and effective | 44 |
springer nature remains | 44 |
in balb c | 44 |
therapeutic efficacy of | 44 |
nature remains neutral | 44 |
jurisdictional claims in | 44 |
the most promising | 44 |
of patients in | 44 |
of public health | 44 |
be used in | 44 |
susceptibility to sars | 44 |
test for sars | 44 |
of more than | 44 |
in published maps | 44 |
testing for sars | 44 |
as early as | 44 |
are susceptible to | 44 |
phase i clinical | 44 |
and surface stability | 44 |
characteristics of covid | 44 |
the control group | 44 |
tested negative for | 44 |
regard to jurisdictional | 44 |
is a highly | 44 |
innate immune system | 44 |
not associated with | 44 |
replication of the | 44 |
maps and institutional | 44 |
in sars coronavirus | 44 |
was approved by | 44 |
was defined as | 44 |
time reverse transcription | 44 |
an urgent need | 44 |
development of new | 44 |
distribution of ace | 44 |
other human coronaviruses | 44 |
patients who were | 43 |
of infectious diseases | 43 |
in clinical samples | 43 |
results indicate that | 43 |
number of covid | 43 |
the evaluation of | 43 |
public health measures | 43 |
by means of | 43 |
composition and divergence | 43 |
like to thank | 43 |
conflicts of interest | 43 |
the need to | 43 |
compared to other | 43 |
due to covid | 43 |
of t cells | 43 |
samples from patients | 43 |
surface stability of | 43 |
loss of smell | 43 |
patients with suspected | 43 |
there has been | 43 |
infection in children | 43 |
laboratory diagnosis of | 43 |
and divergence of | 43 |
of infection in | 43 |
republic of china | 43 |
in the field | 43 |
the new york | 43 |
the susceptibility of | 43 |
an update on | 43 |
specimens of infected | 43 |
neutralizing monoclonal antibodies | 43 |
those of the | 43 |
carried out in | 43 |
suggest that sars | 43 |
effect of the | 43 |
are more likely | 43 |
rbd of sars | 43 |
patients with confirmed | 43 |
the sequence of | 43 |
been identified as | 43 |
cytokine storm syndromes | 43 |
national institutes of | 43 |
a potent inhibitor | 43 |
in treatment of | 43 |
from the same | 43 |
in view of | 43 |
acts as a | 43 |
cases and deaths | 43 |
spike protein in | 43 |
the patients with | 43 |
the degree of | 43 |
serine protease tmprss | 43 |
to determine whether | 43 |
are summarized in | 43 |
amino acid substitutions | 43 |
in mice and | 43 |
of hydroxychloroquine and | 43 |
be explained by | 43 |
cellular immune responses | 43 |
a role for | 43 |
considered as a | 43 |
by using the | 43 |
primers and probes | 43 |
at increased risk | 43 |
the regulation of | 43 |
cell entry of | 43 |
human coronavirus infections | 43 |
from the first | 42 |
in our analysis | 42 |
caused by severe | 42 |
storm syndromes and | 42 |
crucial role in | 42 |
and therapeutic options | 42 |
patients suffering from | 42 |
potent neutralization of | 42 |
were negative for | 42 |
the search for | 42 |
in south korea | 42 |
of mers coronavirus | 42 |
the phylogenetic tree | 42 |
peripheral blood mononuclear | 42 |
highly expressed in | 42 |
of ace expression | 42 |
on the use | 42 |
to the spike | 42 |
have to be | 42 |
there were no | 42 |
is an urgent | 42 |
tissue distribution of | 42 |
an inhibitor of | 42 |
and incubated for | 42 |
mutation in the | 42 |
treatment for covid | 42 |
were carried out | 42 |
as described in | 42 |
note springer nature | 42 |
low levels of | 42 |
basis of sars | 42 |
risk of severe | 42 |
of symptom onset | 42 |
followed by the | 42 |
characteristics of and | 42 |
resulting in a | 42 |
high expression of | 42 |
factors such as | 42 |
the study of | 42 |
to test the | 42 |
a member of | 42 |
it was shown | 42 |
the aim of | 42 |
the start of | 42 |
a consequence of | 42 |
targets for the | 42 |
cell responses in | 42 |
converting enzyme in | 42 |
to predict the | 42 |
with an ic | 42 |
as one of | 42 |
clinical features and | 42 |
in this article | 42 |
of influenza a | 42 |
disease severity and | 42 |
have demonstrated that | 42 |
of ace protein | 42 |
a set of | 42 |
of cases from | 42 |
during the outbreak | 42 |
basic reproduction number | 42 |
of the respiratory | 42 |
recent insights into | 42 |
patients with acute | 42 |
the epithelial cells | 42 |
a critical role | 42 |
to mothers with | 42 |
to estimate the | 42 |
the symptoms of | 42 |
the coronaviridae family | 42 |
the complement system | 42 |
exposed to sars | 42 |
consider cytokine storm | 42 |
neutralizing antibodies and | 42 |
therapeutic options for | 42 |
declare no conflict | 42 |
belonging to the | 42 |
the probability of | 42 |
patients with the | 41 |
in the csf | 41 |
antiviral activity and | 41 |
has the potential | 41 |
coronaviruses in the | 41 |
rna polymerase from | 41 |
by the severe | 41 |
transmission potential of | 41 |
into the cell | 41 |
and more than | 41 |
the administration of | 41 |
to the cell | 41 |
the efficiency of | 41 |
incubated for h | 41 |
in the nasal | 41 |
can be considered | 41 |
that patients with | 41 |
in a small | 41 |
host response to | 41 |
the novel sars | 41 |
of and important | 41 |
the first time | 41 |
after onset of | 41 |
coronavirus s protein | 41 |
to interact with | 41 |
were tested for | 41 |
reported to have | 41 |
in this work | 41 |
we believe that | 41 |
humoral and cellular | 41 |
confirmed cases and | 41 |
trial of lopinavir | 41 |
for viral replication | 41 |
and lower respiratory | 41 |
respiratory specimens of | 41 |
and important lessons | 41 |
of the data | 41 |
of viral shedding | 41 |
findings of covid | 41 |
crystal structures of | 41 |
in a large | 41 |
a broad spectrum | 41 |
and infectious diseases | 41 |
to human ace | 41 |
compared to those | 41 |
syndromes and immunosuppression | 41 |
a cohort of | 41 |
response in patients | 41 |
important lessons from | 41 |
research and development | 41 |
of the renin | 41 |
the safety of | 41 |
are similar to | 41 |
be the most | 41 |
vaccines against sars | 41 |
context of the | 41 |
high viral load | 41 |
a basis for | 41 |
binding of sars | 41 |
porcine epidemic diarrhea | 41 |
is expected to | 41 |
performed using the | 41 |
blood mononuclear cells | 41 |
of chest ct | 41 |
the first step | 41 |
emerging human coronavirus | 41 |
institutes of health | 41 |
are in the | 41 |
azithromycin as a | 41 |
the p position | 41 |
as a novel | 41 |
been used for | 41 |
a potential therapeutic | 41 |
their ability to | 41 |
on the viral | 41 |
its ability to | 40 |
outbreak of pneumonia | 40 |
cov n protein | 40 |
and azithromycin as | 40 |
might be a | 40 |
that the s | 40 |
correlates of protection | 40 |
viruses related to | 40 |
is present in | 40 |
considered as the | 40 |
was determined by | 40 |
rna was extracted | 40 |
and duration of | 40 |
of these viruses | 40 |
of confirmed cases | 40 |
with a history | 40 |
hepatitis b virus | 40 |
a potential target | 40 |
and other respiratory | 40 |
of a report | 40 |
disseminated intravascular coagulation | 40 |
have been associated | 40 |
essential for the | 40 |
in close contact | 40 |
cell responses to | 40 |
i and ii | 40 |
protein of the | 40 |
is the main | 40 |
to form a | 40 |
in agreement with | 40 |
of the lungs | 40 |
rest of the | 40 |
genome sequences of | 40 |
a first step | 40 |
patients with middle | 40 |
development of an | 40 |
with the human | 40 |
the first cases | 40 |
we would like | 40 |
may be used | 40 |
protection against sars | 40 |
evidence of the | 40 |
the binding affinity | 40 |
viral shedding in | 40 |
to the hospital | 40 |
by a sars | 40 |
focus on the | 40 |
more severe disease | 40 |
that do not | 40 |
immune system and | 40 |
to play a | 40 |
of the three | 40 |
reactivity with sars | 40 |
and the virus | 40 |
the stability of | 40 |
glycoprotein of the | 40 |
referred to as | 40 |
the state of | 40 |
from an asymptomatic | 39 |
to our knowledge | 39 |
for mortality of | 39 |
has led to | 39 |
difference between the | 39 |
in cancer patients | 39 |
is critical for | 39 |
in light of | 39 |
severe coronavirus disease | 39 |
outbreak of novel | 39 |
plays an important | 39 |
load in upper | 39 |
inhibits the replication | 39 |
of infected cells | 39 |
mortality of adult | 39 |
to the lack | 39 |
are presented in | 39 |
effectiveness of convalescent | 39 |
a novel human | 39 |
protein is the | 39 |
pathological findings of | 39 |
defined as the | 39 |
seen in the | 39 |
the diagnosis and | 39 |
syndrome in children | 39 |
a public health | 39 |
after the first | 39 |
receptor of sars | 39 |
critical role in | 39 |
activity of sars | 39 |
clinical and laboratory | 39 |
and clinical features | 39 |
of an open | 39 |
in the serum | 39 |
the cl pro | 39 |
the virus into | 39 |
were identified in | 39 |
the exception of | 39 |
from severe acute | 39 |
cases have been | 39 |
course and risk | 39 |
been identified in | 39 |
of the cases | 39 |
and those with | 39 |
in human cells | 39 |
the emerging human | 39 |
course and outcomes | 39 |
the reduction of | 39 |
the appearance of | 39 |
increased risk for | 39 |
of the vaccine | 39 |
the rapid spread | 39 |
into emerging coronaviruses | 39 |
other rna viruses | 39 |
most of these | 39 |
positive and negative | 39 |
insights into emerging | 39 |
in the course | 39 |
several studies have | 39 |
and inhibition of | 39 |
results from the | 39 |
infected with mers | 39 |
vitro antiviral activity | 39 |
antibody response to | 39 |
options for the | 39 |
the gastrointestinal tract | 39 |
to increase the | 39 |
of the samples | 39 |
pathogenesis of coronaviruses | 39 |
be required to | 39 |
estimated to be | 39 |
the mechanisms of | 39 |
can be a | 39 |
intrauterine vertical transmission | 39 |
critically ill covid | 39 |
binding site of | 39 |
of the rbd | 39 |
treatment of novel | 39 |
or in combination | 39 |
has resulted in | 39 |
may have a | 39 |
patients who died | 39 |
and t cell | 39 |
with the same | 39 |
and evaluation of | 39 |
adaptive immune response | 38 |
use of corticosteroids | 38 |
as a model | 38 |
responses against sars | 38 |
duration of the | 38 |
studies have demonstrated | 38 |
with severe disease | 38 |
of adult inpatients | 38 |
to sars cov | 38 |
one of these | 38 |
outbreak of coronavirus | 38 |
a single dose | 38 |
manifestations of sars | 38 |
the viral entry | 38 |
led to a | 38 |
coronavirus infection of | 38 |
with the use | 38 |
exposure to the | 38 |
with the s | 38 |
animals to humans | 38 |
pathogenicity of sars | 38 |
there are several | 38 |
in vivo studies | 38 |
in the cell | 38 |
was conducted in | 38 |
and could be | 38 |
is a potential | 38 |
from animals in | 38 |
systemic lupus erythematosus | 38 |
of disease severity | 38 |
b and c | 38 |
the pathophysiology of | 38 |
liu et al | 38 |
increased levels of | 38 |
effects of the | 38 |
protein in the | 38 |
was based on | 38 |
activity in vitro | 38 |
discovery of a | 38 |
effective against sars | 38 |
the interaction with | 38 |
affected by covid | 38 |
ritonavir in adults | 38 |
this may be | 38 |
coronavirus replication in | 38 |
immunogenicity of a | 38 |
adult inpatients with | 38 |
public health and | 38 |
as the most | 38 |
of infection with | 38 |
inflammatory syndrome in | 38 |
is expressed in | 38 |
nucleocapsid protein of | 38 |
the cell membrane | 38 |
the infectivity of | 38 |
have already been | 38 |
interaction of the | 38 |
in the clinical | 38 |
inpatients with covid | 38 |
is not yet | 38 |
rbd of the | 38 |
more than one | 38 |
disease in the | 38 |
which have been | 38 |
the scientific community | 38 |
for viral entry | 38 |
knowledge of the | 38 |
the s gene | 38 |
in the us | 38 |
with the exception | 38 |
induced by sars | 38 |
is effective in | 38 |
approved the final | 38 |
was shown that | 38 |
ace in the | 38 |
proven to be | 38 |
the intermediate host | 38 |
to patients with | 38 |
impact of the | 38 |
the sars cov | 38 |
the current sars | 38 |
by using a | 38 |
and the sars | 38 |
viral and host | 38 |
treatment options for | 37 |
institutional review board | 37 |
in the transmission | 37 |
has not yet | 37 |
has been associated | 37 |
of the major | 37 |
hydrogen bonds with | 37 |
in vitro activity | 37 |
admitted to hospital | 37 |
study on the | 37 |
ebola virus disease | 37 |
studies showed that | 37 |
the concentration of | 37 |
were inoculated with | 37 |
comparison of the | 37 |
initiative on sharing | 37 |
use of remdesivir | 37 |
believed to be | 37 |
model of sars | 37 |
load of sars | 37 |
neurologic manifestations of | 37 |
the inflammatory response | 37 |
the day of | 37 |
but it is | 37 |
of cell entry | 37 |
results in a | 37 |
resulted in the | 37 |
of chloroquine and | 37 |
could be detected | 37 |
the current study | 37 |
high prevalence of | 37 |
to infect humans | 37 |
a retrospective study | 37 |
global initiative on | 37 |
and clinical trials | 37 |
emergence of a | 37 |
models for sars | 37 |
up to of | 37 |
it could be | 37 |
with a higher | 37 |
hydroxychloroquine for the | 37 |
and vaccines for | 37 |
ncov infected patients | 37 |
responses in covid | 37 |
outbreak in wuhan | 37 |
overview of the | 37 |
a median of | 37 |
have the potential | 37 |
between the sars | 37 |
the nature of | 37 |
the type of | 37 |
tested for sars | 37 |
recent studies have | 37 |
chronic obstructive pulmonary | 37 |
were subjected to | 37 |
the gold standard | 37 |
the influence of | 37 |
the centers for | 37 |
and s subunits | 37 |
of rna viruses | 37 |
the disease and | 37 |
supplementary table s | 37 |
viral life cycle | 37 |
of vaccines and | 37 |
such as influenza | 37 |
half of the | 37 |
specific human monoclonal | 37 |
vaccines for covid | 37 |
around the globe | 37 |
do not have | 37 |
specificity of the | 37 |
was confirmed by | 37 |
of the main | 37 |
features of the | 37 |
days after onset | 37 |
at least days | 37 |
four structural proteins | 37 |
potential target for | 37 |
is crucial to | 37 |
on the same | 37 |
and disease severity | 37 |
to be considered | 37 |
is crucial for | 37 |
obstructive pulmonary disease | 37 |
a treatment of | 37 |
at this time | 37 |
as a therapeutic | 37 |
suspected or confirmed | 37 |
is necessary for | 37 |
s protein was | 37 |
a dna vaccine | 37 |
and may be | 37 |
epidemiological characteristics of | 37 |
contact with a | 37 |
viral entry and | 37 |
for the emerging | 37 |
may be due | 36 |
identification of sars | 36 |
cases in the | 36 |
humans and animals | 36 |
and adaptive immune | 36 |
animal model for | 36 |
coronavirus as a | 36 |
case report of | 36 |
to explore the | 36 |
be an effective | 36 |
in infected cells | 36 |
on coronavirus disease | 36 |
indicates that the | 36 |
children with covid | 36 |
higher than the | 36 |
have been detected | 36 |
virus has been | 36 |
this study are | 36 |
respiratory syndrome a | 36 |
severe acute lung | 36 |
with a single | 36 |
be effective against | 36 |
with atypical pneumonia | 36 |
sequences of the | 36 |
recognition by sars | 36 |
work was supported | 36 |
acute respiratory infection | 36 |
in a dose | 36 |
because of its | 36 |
should be taken | 36 |
a recent report | 36 |
leading to a | 36 |
a narrative review | 36 |
viral rna and | 36 |
supported by a | 36 |
susceptibility of ferrets | 36 |
result of the | 36 |
on virus entry | 36 |
the same clade | 36 |
in a community | 36 |
interfere with the | 36 |
in the prevention | 36 |
in spike protein | 36 |
of immune cells | 36 |
and did not | 36 |
against severe acute | 36 |
antiviral effects of | 36 |
a concentration of | 36 |
the loss of | 36 |
evidence for the | 36 |
target for vaccine | 36 |
in more than | 36 |
is related to | 36 |
are included in | 36 |
from symptom onset | 36 |
and analysis of | 36 |
after visiting wuhan | 36 |
the first week | 36 |
bat cov ratg | 36 |
assessment of the | 36 |
effects of chloroquine | 36 |
was performed in | 36 |
studies are required | 36 |
model for sars | 36 |
consists of a | 36 |
a h n | 36 |
the lung and | 36 |
i and type | 36 |
of a covid | 36 |
cq and hcq | 36 |
sars coronavirus from | 36 |
virus to the | 36 |
in the rbd | 36 |
replication in vitro | 36 |
to support the | 36 |
a prospective study | 36 |
of the c | 36 |
declare no competing | 36 |
weeks after the | 36 |
of viruses related | 36 |
onset of the | 36 |
coronavirus envelope protein | 36 |
in the cytoplasm | 36 |
and its implications | 36 |
to the presence | 36 |
and the number | 36 |
have recovered from | 36 |
impact of covid | 35 |
development of covid | 35 |
in china the | 35 |
view of the | 35 |
as a receptor | 35 |
presence of viral | 35 |
huang et al | 35 |
included in this | 35 |
in the infected | 35 |
and characteristics of | 35 |
it is necessary | 35 |
development of the | 35 |
in understanding sars | 35 |
in at least | 35 |
and vaccine development | 35 |
may be more | 35 |
national health commission | 35 |
in the heart | 35 |
nonhuman primate model | 35 |
are necessary to | 35 |
only a few | 35 |
c r i | 35 |
more than million | 35 |
standard of care | 35 |
the understanding of | 35 |
and oropharyngeal swabs | 35 |
in the management | 35 |
patient with atypical | 35 |
distribution of the | 35 |
to the study | 35 |
the date of | 35 |
hospitalized with covid | 35 |
the n k | 35 |
were performed in | 35 |
coronavirus in dromedary | 35 |
animals in southern | 35 |
period of time | 35 |
lopinavir ritonavir in | 35 |
from animals to | 35 |
clinical trial of | 35 |
in our cohort | 35 |
atypical pneumonia after | 35 |
children and adolescents | 35 |
in the range | 35 |
of mutations in | 35 |